Actively Recruiting
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
Led by University Hospital, Bordeaux · Updated on 2025-09-04
500
Participants Needed
1
Research Sites
729 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic sclerosis (SSc) is a rare form of connective tissue disease characterized by vascular involvement and the intensity of fibrosis. The lack of available treatment is largely due to the very fragmented understanding of the pathophysiology of SSc. However, one of the keys to conducting quality research on this disease remains the development of well-documented patient cohorts with reliable biological samples. The main objective of this cohort is to study the natural progression of SSc in a cohort of patients followed over 5 years.
CONDITIONS
Official Title
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years old
- Diagnosed with systemic scleroderma according to ACR/EULAR 2013 criteria or very early systemic sclerosis defined by Raynaud's phenomenon and specific auto-antibodies
- Affiliated with or benefiting from a social security scheme
- Provided free, informed, and written consent before participation
You will not qualify if you...
- Pregnant or breastfeeding women
- Patients under guardianship, curatorship, or any other legal protection regime
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Bordeaux - service de rhumatologie
Bordeaux, France
Actively Recruiting
Research Team
M
Marie-Elise TRUCHETET, MD, PhD
CONTACT
T
Thomas BARNETCHE, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here